Text and Data Mining valid from 2018-08-10
Received: 13 November 2017
Accepted: 2 July 2018
First Online: 10 August 2018
Change Date: 5 September 2018
Change Type: Update
Change Details: This Article was originally published without the accompanying Peer Review File. This file is now available in the HTML version of the Article; the PDF was correct from the time of publication.
: A patent application to the US patent office is pending. D.P.C. has done consulting for Abbvie, Adaptimmune, Agenus, Amgen, Ariad, AstraZeneca, Biocept, Boehringer Ingelheim, Bristol Myers-Squibb (BMS), Celgene, Foundation Medicine, Genentech/Roche, Gritstone, Guardant Health, Inovio, Merck, MSD, Novartis, Palobiofarma, Pfizer, prIME Oncology, Stemcentrx, Takeda, and has unrelated grant support from BMS. The remaining authors declare no competing interests.